Novartis India Limited (BOM: 500672)

Market Cap	26.51B
Revenue (ttm)	3.37B
Net Income (ttm)	906.70M
Shares Out	24.69M
EPS (ttm)	36.71
PE Ratio	29.25
Forward PE	n/a
Dividend	25.00 (2.33%)
Ex-Dividend Date	Jul 23, 2024

Volume	10,998
Open	1,081.00
Previous Close	1,069.45
Day's Range	1,056.60 - 1,098.50
52-Week Range	599.95 - 1,240.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Novartis India

Novartis India Limited operates as a healthcare company in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neurosciences products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is based in Mumbai, India. The company is a subsidiary of Novartis AG.

• Industry: Pharmaceutical Preparations
• Founded: 1947
• Employees: 62
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500672

Financial Performance

In 2023, Novartis India's revenue was 3.35 billion, a decrease of -11.53% compared to the previous year's 3.79 billion. Earnings were 851.90 million, a decrease of -17.58%.